Current status and performance goals for serum thyroglobulin assays

Clinical Chemistry

Volumn 42, Issue 1, 1996, Pages 164-173

  Spencer, Carole A ^a   Takeuchi, Michael ^a   Kazarosyan, Margarita ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

immunochemiluminometric assay; immunometric assay; radioimmunoassay; thyroid carcinoma; thyrotropin

Indexed keywords

THYROGLOBULIN;

ACCURACY; CHEMOLUMINESCENCE; CONFERENCE PAPER; HUMAN; LABORATORY DIAGNOSIS; PATIENT MONITORING; PROGNOSIS; RADIOIMMUNOASSAY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA;

IMA;

EID: 0030048306     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.1.164     Document Type: Conference Paper

References (54)

1. 125I] thyroglobulin labels for radioimmunoassay use. J Clin Endocrinol Metab 1982;54:581-6.
2. 125I labeled thyroglobulin preparations. Clin Chim Acta 1985;151: 121-32.
3. 125I thyroglobulin tracer heterogeneity on serum Tg RIA measurement. Clin Chim Acta 1985;153:105-15.
4. Black EG, Hoffenberg R. Should one measure serum thyroglobulin in the presence of anti-thyroglobulin antibodies? Clin Endocrinol 1983;19:597-601.
5. Spencer C, Lai-Rosenfeld AO, Guttler RB, LoPresti J, Marcus AO, Nimalasuriya A, et al. Thyrotropin secretion in thyrotoxic and thyroxine-treated patients: assessment by a sensitive immunoenzymometric assay. J Clin Endocrinol Metab 1986;63:349-55.
6. Feldt-Rasmussen U, Schlumberger M. European interiaboratory comparison of serum thyroglobulin measurement. J Endocrinol Invest 1988;11:175-81.
7. Cole TG, Johnson D, Eveland BJ, Nahm MH. Cost-effective method for detection of "hook effect" in tumor marker immunometric assays [Letter]. Clin Chem 1993;39:695-6.
8. Mariotti S, Barbesino G, Caturegli P, Marino M, Manetti L, Pacini F, et al. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal? J Clin Endocrinol Metab 1995;80: 468-72.
9. Feldt-Rasmussen U, Profilis C, Colinet E, Schlumberger M, Black E. Purification and assessment of stability and homogeneity of human thyroglobulin reference material (CRM 457). Exp Clin Endocrinol 1994;102:87-91.
10. Kiso Y, Furmaniak J, Morteo C, Smith BR. Analysis of carbohydrate residues on human thyroid peroxidase (TPO) and thyroglobulin (Tg) and effects of deglycosylation, reduction and unfolding on autoantibody binding. Autoimmunity 1992;12:259-69.
11. Sinadinovic J, Cvejic D, Savin S, Jancic-Zuguricas M, Micic JV. Altered terminal glycosylation of thyroglobulin in papillary thyroid carcinoma. Exp Clin Endocrinol 1992;100:124-8.
12. Saboori AM, Rose NR, Kuppers RC, Butscher WG, Bresler HS, Burek CL. Immunoreactivity of multiple molecular forms of human thyroglobulin. Clin Immunol Immunopathol 1994;72:121-8.
13. Schulz R, Bethauser H, Stempka L, Heilig B, Moll A, Hufner M. Evidence for immunological differences between circulating and tissue-derived thyroglobulin in men. Eur J Clin Invest 1989;19: 459-63.
14. Hufner M, Kiehne B, Stempka L, Bethauser H, Schulz R. Description of a variably expressed and labile epitope of thyroglobulin and its occurrence in different thyroid diseases using a monoclonal antibody. Clin Physiol Biochem 1992;9:35-40.
15. Sugawa H, Smith E, Imura H, Mori T. A thyroid cancer specific monoclonal antibody which recognizes cryptic epitope(s) of human thyroglobulin. Mol Cell Endocrinol 1993;93:207-11.
16. Yamamoto K, Tsuji T, Tarutani O, Osawa T. Structural changes of carbohydrate chains of human thyroglobulin accompanying malignant transformation of thyroid glands. Eur J Biochem 1984;143: 133-44.
17. Hay ID, Bayer MF, Kaplan MM, Klee GG, Larsen PR, Spencer CA. American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays. Clin Chem 1991;37:2002-8.
18. Spencer CA, Takeuchi M, Kazarosyan M, MacKenzie F, Beckett GJ, Wilkinson E. Interlaboratory/intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on reliability of measurement of subnormal concentrations of TSH. Clin Chem 1995;41:367-74.
19. Feldt-Rasmussen U, Petersen PH, Blaabjerg O, Hørder M. Long-term variability in serum thyroglobulin and thyroid related hormones in healthy subjects. Acta Endocrinol (Copenh) 1980;95: 328-34.
20. Spencer CA, Wang C. Thyroglobulin measurement: techniques, clinical benefits and pitfalls. Endocrinol Metab Clin North Am 1995;in press.
21. Meier C, Braverman L, Ebner S, Veronikis I, Daniels G, Ross D, et al. Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (Phase I/II study). J Clin Endocrinol Metab 1994;78:188-96.
22. 131I and antithyroid drugs. Clin Endocrinol 1979;11:585-94.
23. Bodlaender P, Arjonilla JR, Sweat R, Twomey SL. A practical radioimmunoassay of thyroglobulin. Clin Chem 1978;24:267-71.
24. Lubin E, Mechlis-Frish S, Zatz S, Shimoni A, Segal K, Avraham A, et al. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nucl Med 1994;35:257-62.
25. Shah DH, Dandekar SR, Jeevanram RK, Kumar A, Sharma SM, Ganatra RD. Serum thyroglobulin in differentiated thyroid carcinoma: histological and metastatic classification. Acta Endocrinol (Copenh) 1981;98:222-6.
26. Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli JP, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1986;63:960-7.
27. Bayer M, Kriss JP. A solid phase, sandwich-type radioimmunoassay for antithyroglobulin: elimination of false positive results and semiquantitative measurement of antithyroglobulin in the presence of elevated thyroglobulin. J Clin Endocrinol Metab 1979;49: 565-71.
28. Ikekubo K, Jutton J, Schneider AB. Radioimmunoassay of human thyroglobulin with use of "thyroglobulin-free" plasma prepared by ultracentrifugation as diluent. Clin Chem 1980;26:1566-8.
29. Boscato LM, Stuart MC. Heterophilic antibodies: a problem for all immunoassays. Clin Chem 1988;34:27-33.
30. Albert WHW. The antibody/antiserum as an analytical reagent in quantitative immunoassays. Scand J Clin Lab Invest 1991;51: 79-85.
31. Piechaczyk M, Bouanani M, Salhi SL, Baidet L, Bastide M, Pau B, Bastide JM. Antigenic domains on the human thyroglobulin molecule recognized by autoantibodies in patient's sera and by natural autoantibodies isolated from the sera of healthy subjects. Clin Immunol Immunopathol 1987;45:114-21.
32. Bouanani M, Piechaczyk M, Pau B, Bastide M. Significance of the recognition of certain antigenic regions on the human thyroglobulin molecule by natural autoantibodies from healthy subjects. J Immunol 1989;143:1129-32.
33. Bouanani M, Dietrich G, Hurez V, Kaveri SV, Del Rio M, Pau B, Kazatchkine MD. Age-related changes in specificity of human natural autoantibodies to thyroglobulin. J Autoimmun 1993;6: 639-48.
34. Schneider AB, Pervos R. Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin autoantibodies. J Clin Endocrinol Metab 1978;47:126-37.
35. Ericsson UB, Christensen SB, Thorell JI. A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid disease as measured with a sensitive solid-phase immunosorbent radioassay. Clin Immunol Immunopathol 1985;37: 154-62.
36. Tamaki H, Katsumaru H, Amino N, Nakamoto H, Ishikawa E, Miyai K. Usefulness of thyroglobulin antibody detected by ultrasensitive enzyme immunoassay: a good parameter for immune surveillance in healthy subjects and for prediction of post-partum thyroid dysfunction. Clin Endocrinol 1992;37:266-73.
37. Prentice LM, Phillips DIW, Sarsero D, Beever K, McLachlan S, Rees-Smith B. Geographical distribution of subclinical autoimmune thyroid disease in Britain: a study using highly sensitive direct assays for autoantibodies to thyroglobulin and thyroid peroxidase. Acta Endocrinol (Copenh) 1990;123:493-8.
38. Pacini F, Mariotti S, Formica N, Elisei R. Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumor outcome. Acta Endocrinol 1988;119:373-80.
39. Rubello D, Glrelli ME, Casara D, Piccolo M, Perin A, Busnardo B. Usefulness of the combined antithyroglobulin antibodies and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer. J Endocrinol Invest 1990;13:737-42.
40. Rubello D, Casara D, Girelli ME, Piccolo M, Busnardo B. Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid cancer: a prospective study. J Nucl Med 1992;33: 1478-80.
41. Pacini F, Pinchera A, Giani C, Grasso L, Doveri F, Baschieri L. Serum thyroglobulin in thyroid carcinoma and other disorders. J Endocrinol Invest 1980;3:283-92.
42. Rodbard D. "Specific" interference (parallel displacement) in radioligand assays by extraneous binding proteins. Endocrinology 1977;101:1180-3.
43. Mariotti S, Cupini C, Giani C, Lari R, Rolleri E, Falco A, et al. Evaluation of a solid-phase immunoradiometric assay (IRMA) for serum thyroglobulin: effect of anti-thyroglobulin autoantibody. Clin Chim Acta 1982;123:347-55.
44. Ligabue A, Poggioli MC, Zacchini A. Interference of specific autoantibodies in the assessment of serum thyroglobulin. J Nucl Biol Med 1993;37:273-9.
45. Black EG, Cassoni A, Gimlette TMD, Harmer CL, Maisey MN, Oates GD, et al. Serum thyroglobulin in thyroid cancer. Lancet 1981;ii:443-5.
46. Black EG, Sheppard MC, Hoffenberg R. Serial serum thyroglobulin measurements in the management of differentiated thyroid carcinoma. Clin Endocrinol 1987;27:115-20.
47. Black EG, Sheppard MC. Serum thyroglobulin measurements in thyroid cancer: evaluation of 'false' positive results [Letter]. Clin Endocrinol 1991;35:519-20.
48. Piechaczyk M, Baldet L, Pau B, Bastide JM. Novel immunoradiometric assay of thyroglobulin in serum with use of monoclonal antibodies selected for lack of cross-reactivity with autoantibodies. Clin Chem 1989;35:422-4.
49. Ruf J, Carayon P, Lissitzky S. Various expressions of a unique anti-human thyroglobulin antibody repertoire in normal state and autoimmune disease. Eur J Immunol 1985;15:268-72.
50. Schneider A, Ikekubo K, Kuma K. Iodine content of serum thyroglobulin in normal individuals and patients with thyroid cancer. J Clin Endocrinol Metab 1983;57:1251-6.
51. Sapin R, Gasser F, Chambron J. Recovery determination in 600 sera analyzed for thyroglobulin with a recently commercialized IRMA kit [Letter]. Clin Chem 1992;38:1920-1.
52. Weigle WO, High GJ. The behavior of autologous thyroglobulin in the circulation of rabbits immunized with either heterologous or altered homologous thyroglobulin. J Immunol 1967;98:1105-14.
53. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
54. Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem 1996;42:(this issue).